CTA
RETA

Colonial Trust Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Colonial Trust Advisors’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5
Closed -$510 – 934
2023
Q2 		$510 Hold
5
– – ﹤0.01% 838
2023
Q1 		$455 Hold
5
– – ﹤0.01% 838
2022
Q4 		$190 Buy
+5
New +$190 ﹤0.01% 871